Laser surgery of early glottic cancer in elderly.
Aim of this retrospective study is to evaluate the impact of transoral laser surgery of early glottic cancer in elderly patients in terms of feasibility, disease-free survival, overall survival and organ preservation, in a single Institute (European Institute of Oncology). A total of 122 patients (male/female ratio 113/9), over 70s with untreated early stage glottic cancer, were consecutively evaluated and treated at the European Institute of Oncology from 2000 to 2008. None had contraindications to general anaesthesia and all patients signed informed consent to this surgical treatment. The severity of pre-operative comorbidities and the intra-operative risk were evaluated according to the American Society of Anaesthesiologists Grading classification. All patients underwent laser cordectomies according to the European Laryngological Society classification. Histopathological examination demonstrated no evidence of tumour (pT0) in 19 patients (calculated only in patients with a previous vocal cord biopsy positive for squamous cell carcinoma), pTis in 18, pT1a in 53, pT1b in 16, pT2 in 14 and pT3 in 2, respectively. A 10-year overall survival, a tumour specific survival and a laryngeal tumour-specific survival were, respectively, 64.9%, 84.8% and 94.3%. In conclusion, transoral laser surgery is feasible in elderly patients with early stage glottic cancer, providing good results in terms of disease-free survival, organ preservation and quality of life. Our group of elderly patients had no intra-operative or post-surgical complications and resumed normal activities the day after discharge from hospital. Considering these factors, we can assess, that transoral laser surgery, therefore, represents a modern treatment that should be offered as an alternative to conventional radiotherapy in elderly patients with early glottic cancer referred to medical centres with expertise for this surgical procedure.
Division of Head and Neck Surgery, European Institute of Oncology, Milan, Italy. mohssen.ansarin@ieo.it
M
M
Ansarin
A
A
Cattaneo
L
L
Santoro
M A
MA
Massaro
S F
SF
Zorzi
E
E
Grosso
L
L
Preda
D
D
Alterio
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005931:Glottis; D006801:Humans; D007822:Laryngeal Neoplasms / Q000473:pathology / Q000601:surgery*; D053685:Laser Therapy; D008297:Male; D009367:Neoplasm Staging; D012189:Retrospective Studies
Chest. 2003 Jan;123(1 Suppl):226S-243S
12527582
Laryngoscope. 2006 Sep;116(9 Pt 2 Suppl 111):1-13
16946667
CA Cancer J Clin. 1997 Jan-Feb;47(1):5-27
8996076
Rays. 1997 Jan-Mar;22(1 Suppl):77-81
9250021
Eur Arch Otorhinolaryngol. 2000;257(4):227-31
10867840
J Otolaryngol Head Neck Surg. 2009 Dec;38(6):619-23
19958723
Cancer Treat Rev. 2009 May;35(3):237-45
19100689
Otolaryngol Head Neck Surg. 1998 Jan;118(1):110-4
9450840
Crit Rev Oncol Hematol. 2005 Jan;53(1):71-80
15607935
Eur J Cancer. 1996 Nov;32A(12):2075-81
9014748
Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):385-90
19380362
Cancer. 2000 Feb 1;88(3):648-52
10649260
Crit Rev Oncol Hematol. 2009 Jul;71(1):70-8
19144538
Cancer. 2004 May 1;100(9):1786-92
15112257
Cancer J. 2004 Jan-Feb;10(1):61-6
15000497
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
Laryngoscope. 1998 Feb;108(2):237-42
9473075